ArticleJournal of translational medicine2026
Tumor-targeted aptamer-conjugated engineered bacteria for CXCL9 cytokine delivery in non-small cell lung cancer immunotherapy.
Qinghao Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.